Doxicrit Injection is a broad-spectrum antibacterial formulation containing Doxycycline for Injection USP 100 mg, presented as a lyophilized powder for intravenous infusion only. It belongs to the tetracycline class of antibiotics and is widely used for the treatment of serious and life-threatening bacterial infections when oral therapy is not feasible.
Doxycycline works by inhibiting bacterial protein synthesis, thereby preventing the growth and multiplication of susceptible microorganisms. Doxicrit Injection is effective against a wide range of gram-positive and gram-negative bacteria, as well as atypical pathogens, making it a versatile choice in hospital and critical care settings.
It is commonly indicated for the management of respiratory tract infections, urinary tract infections, skin and soft tissue infections, sexually transmitted infections, rickettsial infections, and other systemic bacterial infections. Due to its reliable efficacy and safety profile, Doxicrit is often used in severe infections requiring intravenous administration.
The formulation is manufactured under strict quality standards to ensure high stability, purity, and consistent therapeutic performance. Doxicrit Injection should be administered only under medical supervision after appropriate reconstitution and dilution, as directed by a healthcare professional.
Doxicrit Injection provides dependable intravenous antibiotic therapy, supporting effective infection control and improved patient outcomes.
This information is for registered medical practitioner only. Anyone other than medical practitioner should consult medical practitioner before using this product.